Inpare ApS: Financial statements 2020
CVR: 37138789
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Inpare ApS (CVR 37138789) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -197,084 and a net result of DKK -132,844 compared with DKK -77,923 the year before. Equity in the 2020 report amounted to DKK -243,329. The company had 2 employees in the financial year.
- Gross Profit
- DKK -197,084
- Profit/Loss
- DKK -132,844
- Equity
- DKK -243,329
- Total Assets
- DKK 118,554
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -197K | -133K | -243K | 2 |
| 2019 | - | -100K | -78K | -110K | 2 |
| 2018 | - | -27K | -26K | -33K | 2 |
| 2017 | 0 | -168K | -133K | -6K | 0 |
Official annual report
How creditworthy is Inpare ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Inpare ApS has published its annual report for 2019. Gross profit came to DKK -99,901, and the net result was DKK -77,923.
About Inpare ApS
Inpare ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2015. The company has been dissolved on 27 November 2024. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Lionheart Pharmaceuticals ApS. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK -218,796 and a net result of DKK -272,847 compared with DKK -142,714 the year before. Equity in the 2023 report amounted to DKK -735,535.